Bibliografia UJ CM

1/20
Cristina Nanni, Carsten Kobe, Bettina Baeßler, Christian Baues, Ronald Boellaard, Peter Borchmann, Andreas Buck, Irene Buvat, Björn Chapuy, Bruce D. Cheson, Robert Chrzan, Ann-Segolene Cottereau, Ulrich Dührsen, Live Eikenes, Martin Hutchings, Wojciech Jurczak, Françoise Kraeber-Bodéré, Egesta Lopci, Stefano Luminari, Steven MacLennan, N. George Mikhaeel, Marcel Nijland, Paula Rodríguez-Otero, Giorgio Treglia, Nadia Withofs, Elena Zamagni, Pier Luigi Zinzani, Josée M. Zijlstra, Ken Herrmann, Jolanta Kunikowska.
European Association of Nuclear Medicine (EANM) Focus 4 consensus recommendations : molecular imaging and therapy in haematological tumours
Lancet. Haematology
2023 : Vol. 10, nr 5, s.e367-e381, bibliogr. 42 poz., sum.
Autor korespondencyjny: Cristina Nanni
e-ISSN: 2352-3026
AZ
POG
AIF
IF: 24.700
Adres url:
Streszczenie w PubMed:
DOI:
2/20
Michael L. Wang, Wojciech Jurczak, Pier Luigi Zinzani, Toby A. Eyre, Chan Y. Cheah, Chaitra S. Ujjani, Youngil Koh, Koji Izutsu, James N. Gerson, Ian Flinn, Benoit Tessoulin, Alvaro J. Alencar, Shuo Ma, David Lewis, Ewa Lech-Maranda, Joanna Rhodes, Krish Patel, Kami Maddocks, Nicole Lamanna, Yucai Wang, Constantine S. Tam, Talha Munir, Hirokazu Nagai, Francisco Hernandez-Ilizaliturri, Anita Kumar, Timothy S. Fenske, John F. Seymour, Andrew D. Zelenetz, Binoj Nair, Donald E. Tsai, Minna Balbas, Richard A. Walgren, Paolo Abada, Chunxiao Wang, Junjie Zhao, Anthony R. Mato, Nirav N. Shah.
Pirtobrutinib in covalent BTK-inhibitor pre-treated mantle cell lymphoma
Journal of Clinical Oncology
2023, il., bibliogr. 35 poz., sum.
Autor korespondencyjny: Michael L. Wang
Online First 2023-05-16
p-ISSN: 0732-183X
XXX
ORG
AIF
IF: 45.300
Adres url:
Streszczenie w PubMed:
3/20
Matthew J. Matasar, Marcelo Capra, Muhit Özcan, Fangfang Lv, Wei Li, Eduardo Yanez, Katya Sapunarova, Tongyu Lin, Jie Jin, Wojciech Jurczak, Aryan Hamed, Ming-Chung Wang, Ross Baker, Igor Bondarenko, Qingyuan Zhang, Jifeng Feng, Klaus Geissler, Mihaela Lazaroiu, Guray Saydam, Árpád Szomor, Krimo Bouabdallah, Rinat Galiulin, Toshiki Uchida, Lidia Mongay Soler, Anjun Cao, Florian Hiemeyer, Aruna Mehra, Barrett H. Childs, Yuankai Shi, Pier Luigi Zinzani.
Copanlisib plus rituximab versus placebo plus rituximab in patients with relapsed indolent non-Hodgkin lymphoma (CHRONOS-3) : a double-blind, randomised, placebo-controlled, phase 3 trial.
Lancet. Oncology
2021 : Vol. 22, nr 5, s. 678-689, il., bibliogr. 34 poz., sum.
Autor korespondencyjny: Matthew J. Matasar.
p-ISSN: 1470-2045
AZ
ORG
AIF
IF: 54.433
Adres url:
Streszczenie w PubMed:
4/20
Matthew S. Davids, Owen A. O'Connor, Wojciech Jurczak, Felipe Samaniego, Timothy S. Fenske, Pier Luigi Zinzani, Manish R. Patel, Nilanjan Ghosh, Bruce D. Cheson, Enrico Derenzini, Danielle M. Brander, James A. Reeves, Wanda Knopinska-Posluszny, John N. Allan, Tycel Phillips, Paolo F. Caimi, Ewa Lech-Maranda, John M. Burke, Richy Agajanian, Ruth Pettengell, Lori A. Leslie, Chan Y. Cheah, Gustavo Fonseca, James H. Essell, Julio C. Chavez, John M. Pagel, Jeff P. Sharman, Yanzhi Hsu, Hari P. Miskin, Peter Sportelli, Michael S. Weiss, Ian W. Flinn.
Integrated safety analysis of umbralisib, a dual PI3Kδ/CK1ε nhibitor, in relapsed/refractory lymphoid malignancies.
Blood Advances
2021 : Vol. 5, nr 23, s. 5332-5343, il., bibliogr. 50 poz., abstr.
Autor korespondencyjny: Matthew S. Davids.
p-ISSN: 2473-9529
e-ISSN: 2473-9537
AZ
ORG
AIF
IF: 7.642
Adres url:
Streszczenie w PubMed:
5/20
Wojciech Jurczak, Simon Rule, William Townsend, David Tucker, Barbara Sarholz, Jurgen Scheele, Martin Dyroff, John G. Gribben, Monika Długosz-Danecka, Pier Luigi Zinzani.
Phase I, first-in-human trial of Bruton's tyrosine kinase inhibitor M7583 in patients with B-cell malignancies.
Leukemia & Lymphoma
2021 : Vol. 62, nr 10, s. 2392-2399, bibliogr., abstr.
Autor korespondencyjny: Jurgen Scheele.
p-ISSN: 1042-8194
e-ISSN: 1029-2403
AZ
ORG
AIF
IF: 2.996
Adres url:
Streszczenie w PubMed:
6/20
Nathan H. Fowler, Felipe Samaniego, Wojciech Jurczak, Nilanjan Ghosh, Enrico Derenzini, James A. Reeves, Wanda Knopinśka-Posłuszny, Chan Y. Cheah, Tycel Phillips, Ewa Lech-Maranda, Bruce D. Cheson, Paolo F. Caimi, Sebastian Grosicki, Lori A. Leslie, Julio C. Chavez, Gustavo Fonseca, Sunil Babu, Daniel J. Hodson, Spencer H. Shao, John M. Burke, Jeff P. Sharman, Jennie Y. Law, John M. Pagel, Hari P. Miskin, Peter Sportelli, Owen A. O'Connor, Michael S. Weiss, Pier Luigi Zinzani.
Umbralisib, a Dual PI3Kδ/CK1ε Inhibitor in Patients With Relapsed or Refractory Indolent Lymphoma.
Journal of Clinical Oncology
2021 : Vol. 39, nr 15, s. 1609-1618, il., bibliogr. 40 poz., abstr.
Autor korespondencyjny: Pier Luigi Zinzani.
Open Access Creative Commons Attribution License CC-BY-NC-ND 4.0.
p-ISSN: 0732-183X
AZ
ORG
AIF
IF: 50.739
Adres url:
Streszczenie w PubMed:
7/20
David J. Straus, Monika Długosz-Danecka, Sergey Alekseev, Arpad Illes, Marco Picardi, Ewa Lech-Maranda, Tatyana Feldman, Piotr Smolewski, Kerry J. Savage, Nancy L. Bartlett, Jan Walewski, Radhakrishnan Ramchandren, Pier Luigi Zinzani, Martin Hutchings, Joseph M. Connors, John Radford, Javier Munoz, Won Seog Kim, Ranjana Advani, Stephen M. Ansell, Anas Younes, Harry Miao, Rachael Liu, Keenan Fenton, Andres Forero-Torres, Andrea Gallamini.
Brentuximab vedotin with chemotherapy for stage III/IV classical Hodgkin lymphoma : 3-year update of the ECHELON-1 study.
Blood
2020 : Vol. 135, nr 10, s. 735-742, il., bibliogr. 19 poz., abstr.
Auto korespondencyjny: David J. Straus.
p-ISSN: 0006-4971
AZ
ORG
AIF
IF: 22.113
Adres url:
8/20
Karin Hohloch, Christine Windemuth-Kieselbach, Pier Luigi Zinzani, Roberto Cacchione, Wojciech Jurczak, C. Suh, Lorens Trumper, Christian W. Scholz.
Radioimmunotherapy for mantle cell lymphoma : 5-year follow-up of 90 patients from the international RIT registry.
Annals of Hematology
2020 : Vol. 99, nr 5, s. 1073-1079, il, bibliogr. 15 poz., abstr.
Autor korespondencyjny: Karin Hohloch.
Open Access Creative Commons Attribution License CC-BY 4.0.
p-ISSN: 0939-5555
AZ
ORG
AIF
IF: 3.673
Adres url:
Streszczenie w PubMed:
9/20
Wojciech Jurczak, Alicja M. Gruszka, Anna Sowa-Staszczak, Monika Dlugosz-Danecka, Marta Szostek, Dagmara Zimowska-Curylo, Agnieszka Giza, Katarzyna Krawczyk, Malgorzata Jakobczyk, Alicja Hubalewska-Dydejczyk, Michal Szymczyk, Tomasz Wróbel, Wanda Knopińska-Posłuszny, Elżbieta Kisiel, Aleksander Skotnicki, Pier Luigi Zinzani.
Consolidation with ⁹⁰Y ibritumomab tiuxetan radioimmunotherapy in mantle cell lymphoma patients ineligible for high dose therapy: results of the phase II multicentre Polish Lymphoma Research Group trial, after 8-year long follow-up.
Leukemia & Lymphoma
2019 : Vol. 60, nr 11, s. 2689-2696, bibliogr., abstr.
Autor korespondencyjny: Wojciech Jurczak.
p-ISSN: 1042-8194
AZ
ORG
AIF
IF: 2.969
Adres url:
Streszczenie w PubMed:
10/20
Michael Wang, Simon Rule, Pier Luigi Zinzani, Andre Goy, Olivier Casasnova, Stephen D. Smith, Gandhi Damaj, Jeanette K. Doorduijn, Thierry Lamy, Franck Morschhauser, Carlos Panizo, Bijal Shah, Andrew Davies, Richard Eek, Jehan Dupuis, Eric Jacobsen, Arnon P. Kater, Steven Le Gouill, Lucie Oberic, Tadeusz Robak, Preetesh Jain, Melanie M. Frigault, Raquel Izumi, Dorothy Nguyen, Priti Patel, Ming Yin, Monika Długosz-Danecka.
Durable response with single-agent acalabrutinib in patients with relapsed or refractory mantle cell lymphoma.
Leukemia
2019 : Vol. 33, nr 11, s. 2762-2766, bibliogr. 6 poz.
Autor korespondencyjny: Michael Wang.
Open Access Creative Commons Attribution License CC-BY 4.0.
p-ISSN: 0887-6924
LR
AIF
IF: 8.665
Adres url:
Streszczenie w PubMed:
11/20
Karin Hohloch, Christiane Windemuth-Kieselbach, Julia Kolz, Pier Luigi Zinzani, Roberto Cacchione, Wojciech Jurczak, Angelika Bischof Delaloye, Lorenz Trumper, Christian W. Scholz.
Radioimmunotherapy (RIT) for Follicular Lymphoma achieves long term lymphoma control in first line and at relapse: 8-year follow-up data of 281 patients from the international RIT-registry.
British Journal of Haematology
2019 : Vol. 184, nr 6, s. 949-956, bibliogr., sum.
Autor korespondencyjny: Karin Hohloch.
p-ISSN: 0007-1048
AZ
ORG
AIF
IF: 5.518
Adres url:
Streszczenie w PubMed:
12/20
Michael Wang, Simon Rule, Pier Luigi Zinzani, Andre Goy, Olivier Casasnovas, Stephen D. Smith, Gandhi Damaj, Jeanette Doorduijn, Thierry Lamy, Franck Morschhauser, Carlos Panizo, Bijal Shah, Andrew Davies, Richard Eek, Jehan Dupuis, Eric Jacobsen, Arnon P. Kater, Steven Le Gouill, Lucie Oberic, Taduesz Robak, Todd Covey, Richa Dua, Ahmed Hamdy, Xin Huang, Raquel Izumi, Priti Patel, Wayne Rothbaum, J. Greg Slatter, Wojciech Jurczak.
Acalabrutinib in relapsed or refractory mantle cell lymphoma (ACE-LY-004): a single-arm, multicentre, phase 2 trial.
Lancet
2018 : Vol. 391, nr 10121, s. 659-667, il., bibliogr. 24 poz., sum.
Autor korespondencyjny: Michael Wang.
p-ISSN: 0140-6736
AZ
ORG
AIF
IF: 59.102
Adres url:
Streszczenie w PubMed:
13/20
Gilles Salles, Stephen J. Schuster, Sven de Vos, Nina D. Wagner-Johnston, Andreas Viardot, Kristie A. Blum, Christopher R. Flowers, Wojciech J. Jurczak, Ian W. Flinn, Brad S. Kahl, Peter Martin, Yeonhee Kim, Sanatan Shreay, Matthias Will, Bess Sorensen, Madlaina Breuleux, Pier Luigi Zinzani, Ajay K. Gopal.
Efficacy and safety of idelalisib in patients with relapsed, rituximab- and alkylating agent-refractory follicular lymphoma: a subgroup analysis of a phase 2 study.
Haematologica
2017 : Vol. 102, nr 4, s. e156-e159, il., bibliogr., abstr.
Open Access Creative Commons Attribution License CC-BY.
Autor korespondencyjny: Ajay K. Gopal.
Data udostępnienia w sposób otwarty: 2016-12-15
p-ISSN: 0390-6078
AZ
ORG
AIF
IF: 9.090
BB: PubMed ; Scopus ; Web of Science Core Collection
PubMed; Scopus; Web of Science Core Collection
Adres url:
Streszczenie w PubMed:
14/20
Wojciech Jurczak, Pier Luigi Zinzani, Gianluca Gaidano, Andre Goy, Mariano Provencio, Zsolt Nagy, Tadeusz Robak, Kami J. Maddocks, Christian Buske, Sumeet Ambarkhane, Mark Winderlich, Maren Dirnberger-Hertweck, Jan Endell, Kristie A. Blum.
Single-Agent MOR208 in Relapsed or Refractory (R-R) Non-Hodgkin's Lymphoma (NHL): Results from Diffuse Large B-Cell Lymphoma (DLBCL) and Indolent NHL Subgroups of a Phase IIa Study.
Blood
2016 : Vol. 128, nr 22, s. 623
58th ASH Annual Meeting & Exposition, San Diego, California, 3-5 December 2016.
p-ISSN: 0006-4971
SZZ
SIF
Adres url:
15/20
Ajay K. Gopal, Brad S. Kahl, Sven Vos, de, Nina D. Wagner-Johnston, Stephen J. Schuster, Wojciech J. Jurczak, Ian W. Flinn, Christopher R. Flowers, Peter Martin, Andreas Viardot, Kristie A. Blum, Andre H. Goy, Andrew J. Davies, Pier Luigi Zinzani, Martin Dreyling, Dave Johnson, Langdon L. Miller, Leanne Holes, Daniel Li, Roger D. Dansey, Wayne R. Godfrey, Gilles A. Salles.
PI3KΔ inhibition by idelalisib in patients with relapsed indolent lymphoma.
New England Journal of Medicine
2014 : Vol. 370, nr 11, s. 1008-1018, il., bibliogr., abstr.
p-ISSN: 0028-4793
AZ
ORG
AIF
IF: 55.873
Adres url:
16/20
Bertrand Coiffier, Evgenii A. Osmanov, Xiaonan Hong, Adriana Scheliga, Jiri Mayer, Fritz Offner, Simon Rule, Adriana Teixeira, Jan Walewski, Sven Vos, de, Michael Crump, Ofer Shpilberg, Dixie-Lee Esseltine, Eugene Zhu, Christopher Enny, Panteli Theocharous, Helgi Velde, van de, Yusri A. Elsayed, Pier Luigi Zinzani, LYM-3001 study investigators.
Bortezomib plus rituximab versus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma : a randomised phase 3 trial.
Lancet. Oncology
2011 : Vol. 12, nr 8, s. 773-784, il., bibliogr. 44 poz., sum.
p-ISSN: 1470-2045
AZ
ORG
AIF
IF: 22.589
17/20
Karin Hohloch, Angelika Bischof Delaloye, Christiane Wildemuth-Kieselbach, Jose Gomez-Codina, Werner Linkesch, Woijciech [Wojciech] Jurczak, Roberto Cacchione, Cheolwon Suh, Pier Luigi Zinzani, Lorenz Trumper.
Radioimmunotherapy confers long-term survival to lymphoma patients with acceptable toxicity : registry analysis by the International Radioimmunotherapy Network.
Journal of Nuclear Medicine
2011 : Vol. 52, nr 9, s. 1354-1360, il., bibliogr. 17 poz.
p-ISSN: 0161-5505
AZ
ORG
AIF
IF: 6.381
18/20
K. Hohloch, P[ier] L. Zinzani, W. Linkesch, W[ojciech] Jurczak, A. Deptala, M. Lorsbach, C. Windemuth-Kiesselbach, G.G. Wulf, L.H. Truemper.
Radioimmunotherapy with ⁹⁰Y-ibritumomab tiuxetan is a safe and efficient treatment for patients with B-cell lymphoma relapsed after auto-SCT: an analysis of the international RIT-Network.
Bone Marrow Transplantation
2011 : Vol. 46, nr 6, s. 901-903, bibliogr. 8 poz.
ISSN: 0268-3369
LR
AIF
IF: 3.746
19/20
Wojciech Jurczak, Aleksander B. Skotnicki, Andrzej Deptala, Christine Windemuth-Kieselbach, Michael Lorsbach, Angelika Bischof Delaloye, Suh Cheolwon, Pier Luigi Zinzani, Roberto Cacchione, Werner Linkesch, Francesco d'Amore, Lorenz H. Truemper.
Consolidation with radioimmunotherapy may prolong survival in first remission of mantle cell lymphoma patients uneligible for stem cell transplantation, an analysis of the International RIT-Network.
Blood
2009 : Vol. 114, nr 22, abstr. 3746
51st ASH Annual Meeting, New Orleans, USA, [5-8 December 2009].
SZZ
SIF
20/20
Pier Luigi Zinzani, Francesco d'Amore, Emilio Bombardieri, Caroline Brammer, Jose Gomez Codina, Tim Illigde, Wojciech Jurczak, Werner Linkesch, Franck Morschhauer, Elisabeth Vendenberghe, Achiel Van Hoof.
Consensus conference : implementing treatment recommendations on yttrium-90 immunotherapy in clinical practice - report of a European workshop.
European Journal of Cancer
2008 : Vol. 44, nr 3, s. 366-373, bibliogr. 44 poz., abstr.
p-ISSN: 0959-8049
AZ
ORG
AIF
IF: 4.475
Wyświetl ponownie stosując format:

Wyświetl/ukryj etykiety | Wyświetlenie wyników w wersji do druku | Pobranie pliku do edytora | Nowe wyszukiwanie | Biblioteka Medyczna UJ